Astellas Pharma's Breakthrough Drug Approved by FDA to Ease Menopausal Symptoms Astellas Pharma, a Tokyo-based pharmaceutical company, has achieved a significant milestone with the approval of its groundbreaking drug by the U.S. Food and Drug Administration (FDA). The drug, fezolinetant, has been given the green light to treat hot flashes and night sweats caused by menopause. Hot flashes and night sweats are among the most distressing and disruptive symptoms experienced by women going through menopause. As estrogen and progesterone production decline during this transitional phase of life, the resulting hormonal imbalance can trigger sudden and intense feelings of warmth, affecting body temperature regulation. Stay Updated: https://thelifesciencesmagazine.com/astellas-pharmas-breakthrough-drug/ #menopause #perimenopause #womenshealth #hormones #health #women #menopausehealth #wellness #news